Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations
NCT07223177
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pediatric sensors within their respective indicated patient populations that have a range of different skin pigmentations, simultaneously with an FDA cleared pulse oximeter as a comparator.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- SpO2
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 0 to 21 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Masimo Corporation
- Last updated on ClinicalTrials.gov
- July 13, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 2
- Paradigm Clinical Research · Modesto, CA
- Paradigm Clinical Research · San Diego, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.